MAPT and Alzheimer disease: Based on an automatic decision tree splitting, we could show that high p‐tau181 levels of >56 pg/mL were the strongest indicator of AD, followed by high temporal tau binding (DVR > 1) and posterior cortical (occipital) hypoperfusion (SUVR0.5–2.5 < 1.2).